Laklai et al. showed that YAP signaling impaired TGF-β activation in association with pancreatic cancer progression in vivo, leading to the accumulation of a fibrotic matrix associated with aggressive tumors and poorer overall survival [51]. This evidence concerns the gene YAP1 and familial pancreatic carcinoma.